248 related articles for article (PubMed ID: 24148324)
41. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ
J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133
[TBL] [Abstract][Full Text] [Related]
42. Effects of clopidogrel on "aspirin specific" pathways of platelet inhibition.
Hobson AR; Qureshi Z; Banks P; Curzen NP
Platelets; 2009 Sep; 20(6):386-90. PubMed ID: 19811222
[TBL] [Abstract][Full Text] [Related]
43. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
44. Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation.
Dörr G; Schmidt G; Gräfe M; Regitz-Zagrosek V; Fleck E
J Cardiovasc Pharmacol; 2002 Apr; 39(4):523-32. PubMed ID: 11904526
[TBL] [Abstract][Full Text] [Related]
45. Can we use adenosine diphosphate (ADP) to study "aspirin resistance"? The Janus faces of ADP-triggered platelet aggregation.
Dobaczewski M; Golański J; Kowalski T; Nocuń M; Rózalski M; Kostka B; Ulicna O; Mussur M; Markuszewski L; Watała C
Pharmacol Rep; 2008; 60(3):361-8. PubMed ID: 18622061
[TBL] [Abstract][Full Text] [Related]
46. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
Dropinski J; Jakiela B; Sanak M; Wegrzyn W; Biernat M; Dziedzina S; Plutecka H; Szczeklik A
Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014
[TBL] [Abstract][Full Text] [Related]
47. Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.
Gurbel PA; Bliden KP; Butler K; Antonino MJ; Wei C; Teng R; Rasmussen L; Storey RF; Nielsen T; Eikelboom JW; Sabe-Affaki G; Husted S; Kereiakes DJ; Henderson D; Patel DV; Tantry US
Circulation; 2010 Mar; 121(10):1188-99. PubMed ID: 20194878
[TBL] [Abstract][Full Text] [Related]
48. Determination of aspirin responsiveness by use of whole blood platelet aggregometry.
Ivandic BT; Giannitsis E; Schlick P; Staritz P; Katus HA; Hohlfeld T
Clin Chem; 2007 Apr; 53(4):614-9. PubMed ID: 17332149
[TBL] [Abstract][Full Text] [Related]
49. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension.
Robbins IM; Kawut SM; Yung D; Reilly MP; Lloyd W; Cunningham G; Loscalzo J; Kimmel SE; Christman BW; Barst RJ
Eur Respir J; 2006 Mar; 27(3):578-84. PubMed ID: 16507859
[TBL] [Abstract][Full Text] [Related]
50. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary.
Linnemann B; Schwonberg J; Mani H; Prochnow S; Lindhoff-Last E
J Thromb Haemost; 2008 Apr; 6(4):677-83. PubMed ID: 18182038
[TBL] [Abstract][Full Text] [Related]
51. Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects.
Tamminen M; Lassila R; Westerbacka J; Vehkavaara S; Yki-Järvinen H
Int J Obes Relat Metab Disord; 2003 Aug; 27(8):907-11. PubMed ID: 12861231
[TBL] [Abstract][Full Text] [Related]
52. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
[TBL] [Abstract][Full Text] [Related]
53. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
54. Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study.
Cuisset T; Frere C; Quilici J; Uhry S; Morange PE; Mouret JP; Gaborit B; Bali L; Moro PJ; Lambert M; Bonnet JL
Thromb Res; 2009 May; 124(1):33-6. PubMed ID: 18990434
[TBL] [Abstract][Full Text] [Related]
55. The effect of ex vivo anticoagulants on whole blood platelet aggregation.
Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA
Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515
[TBL] [Abstract][Full Text] [Related]
56. Assessment of platelet functional activity in healthy individuals and patients receiving antiplatelet therapy. Possible inconsistencies between aggregation and flow cytometry tests.
Bodrova VV; Shustova ON; Golubeva NV; Alieva AK; Vlodzyanovsky VV; Pevzner DV; Mazurov AV
Biomed Khim; 2024 Apr; 70(2):99-108. PubMed ID: 38711409
[TBL] [Abstract][Full Text] [Related]
57. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.
Eikelboom JW; Hankey GJ; Thom J; Claxton A; Yi Q; Gilmore G; Staton J; Barden A; Norman PE
J Thromb Haemost; 2005 Dec; 3(12):2649-55. PubMed ID: 16359503
[TBL] [Abstract][Full Text] [Related]
58. Effects of acetylsalicylic acid on platelet aggregation before and during increase in dietary eicosapentaenoic acid.
Thorngren M; Gustafson A; Wohlfart G
Haemostasis; 1983; 13(4):244-7. PubMed ID: 6311694
[TBL] [Abstract][Full Text] [Related]
59. [Is antiplatelet therapy always effective?].
Remková A; Janušicová A; Remko M
Vnitr Lek; 2012 Dec; 58(12):904-14. PubMed ID: 23427948
[TBL] [Abstract][Full Text] [Related]
60. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography Platelet Mapping.
Collyer TC; Gray DJ; Sandhu R; Berridge J; Lyons G
Br J Anaesth; 2009 Apr; 102(4):492-8. PubMed ID: 19286767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
